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Although it is clear that probiotics improve intestinal barrier function, little is known about 
the effects of probiotics on the aging intestine. We investigated effects of 10-week bac-
terial supplementation of Lactobacillus plantarum WCFS1, Lactobacillus casei BL23, or 
Bifidobacterium breve DSM20213 on gut barrier and immunity in 16-week-old acceler-
ated aging Ercc1−/∆7 mice, which have a median lifespan of ~20 weeks, and their wild-type 
littermates. The colonic barrier in Ercc1−/∆7 mice was characterized by a thin (< 10 μm) 
mucus layer. L. plantarum prevented this decline in mucus integrity in Ercc1−/∆7 mice, 
whereas B. breve exacerbated it. Bacterial supplementations affected the expression of 
immune-related genes, including Toll-like receptor 4. Regulatory T cell frequencies were 
increased in the mesenteric lymph nodes of L. plantarum- and L. casei-treated Ercc1−/∆7 
mice. L. plantarum- and L. casei-treated Ercc1−/∆7 mice showed increased specific
antibody production in a T cell-dependent immune response in vivo. By contrast, the 
effects of bacterial supplementation on wild-type control mice were negligible. Thus, 
supplementation with L. plantarum – but not with L. casei and B. breve – prevented the 
decline in the mucus barrier in Ercc1−/∆7 mice. Our data indicate that age is an important 
factor influencing beneficial or detrimental effects of candidate probiotics. These findings 
also highlight the need for caution in translating beneficial effects of probiotics observed 
in young animals or humans to the elderly.
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inTrODUcTiOn
Aging is accompanied by multiple age-related diseases (1), posing 
a major burden to public health care (2). With age, a decline in 
the regenerative potential of tissues due to stem cell exhaustion 
occurs (3). Turnover in epithelial cells is rapid, and mounting evi-
dence indicates that intestinal stem cells are compromised with 
aging (4). For example, a crucial component of the intestinal bar-
rier is mucus secreted by goblet cells (5). The Muc2 glycoprotein 
regulates immunity by inducing tolerogenic signals in mucosal 
dendritic cells (6) and is important in host–microbe interactions 
(7). Thus, changes in mucus quantity and integrity influence 
immunity (6, 8).
Aging is accompanied by the development of a low-grade 
inflammation (“inflammaging”), which is characterized by 
elevated IL-6 and TNF serum levels in elderly (9). Involution of 
the thymus and the bone marrow (BM) leads to decreased T and 
B cell production (10, 11). By contrast, the production of myeloid 
cells is enhanced with aging, characterized by a progressive 
increase of neutrophil frequencies in the circulation (12).
Probiotics are defined as live bacteria that confer health benefits 
to the host, for example, by competing with pathogens, enhanc-
ing intestinal barrier function, and regulating immunity (13, 14). 
They might, therefore, prevent some of the undesired age-related 
intestinal barrier and immune effects. Probiotic supplementation 
of elderly subjects led to changes in fecal microbiota composition 
(15–17), and affected the distribution and function of NK cells, 
macrophages, granulocytes, and T cells in the circulation (18, 19). 
Supplementation of aged mice with Lactobacillus paracasei resulted 
in increased IgG2a serum titers after antigenic challenge (20). 
Middle-aged mice that were supplemented with Bifidobacterium 
animalis showed decreased colon permeability, extended lifespan, 
and improved quality of life (21). Besides these studies, little is 
known about how exposure to probiotics impacts on the aging 
intestinal barrier and immune system. Moreover, it is unknown 
whether the beneficial effects of probiotics are age dependent.
In this report, we have used an accelerated aging mouse model 
to evaluate the effects of candidate probiotics in aging. Based on 
a variety of histological, functional, metabolomic, and proteomic 
data, it has been concluded that Ercc1−/∆7 mice resemble normal 
murine aging (22). Recently, we have shown that the immune 
system of Ercc1−/∆7 mice resembles the immune system of aged 
WT mice. For instance, we showed a similar decrease in B cell 
precursors and naïve T cells, and a similar increase in memory T 
cells and regulatory T cells (23). The ERCC1 protein is involved 
in multiple DNA repair pathways. Ercc1−/∆7 mice (median lifespan 
~20 weeks) are deficient for fully functional ERCC1 protein. The 
expression of ERCC1-XPF (excision repair cross-complemen-
tation group 1-xeroderma pigmentosum group F) DNA repair 
endonuclease is reduced to ~5% compared with Ercc1+/+ mice. 
Moreover, the residual ERCC1-XPF protein present is expressed 
from a truncated allele, and lacks the last seven amino acids. 
A reduction of ERCC1 protein activity leads to increased accu-
mulation of DNA damage and, hence, results in an accelerated 
aging phenotype (24, 25).
The aim of this study was to investigate the potential of sup-
plementation with candidate probiotic strains to ameliorate the 
effects of aging on the intestinal barrier and the immune system. 
Previously, probiotic activity was documented for Lactobacillus 
plantarum WCFS1 (26–28), Lactobacillus casei BL23 (29, 30), and 
relatives of Bifidobacterium breve DSM20213 (31). We selected 
these strains on the basis of induced IL-10/TNF ratios in young 
and aged immune cells in  vitro (32). The three strains can be 
classified as potential pro-inflammatory (L. plantarum), regula-
tory (L. casei), or anti-inflammatory (B. breve), based on low, 
intermediate, or high IL-10/TNF ratios, respectively.
For this study, we supplemented 6-week-old Ercc1+/+ mice and 
Ercc1−/∆7 mice with L. plantarum, L. casei, or B. breve for 10 weeks. 
Mucus barrier, microbiota composition, and gene regulation in 
the colon were analyzed, as well as the distribution of immune 
cells in various mucosal and peripheral lymphoid organs. We 
determined immune competence by antigenic challenge.
MaTerials anD MeThODs
Mice
The generation and characterization of Ercc1+/∆7 and Ercc1−/+ mice 
has been previously described (25). Ercc1−/∆7 mice were obtained 
by crossing Ercc1+/∆7 with Ercc1−/+ mice of pure C57Bl6/J and FVB 
backgrounds to yield Ercc1−/∆7 with an F1 C57Bl6J/FVB hybrid 
background. Genotyping was performed as described previ-
ously (33). Wild-type littermates (C57Bl6J/FVB F1) were used 
as controls. Four-month-old and 18-month-old C57Bl6/J mice 
were purchased from Harlan (Horst, The Netherlands; only used 
in Figure 1).
Animals were housed in individual ventilated cages under SPF 
conditions. Experiments were performed in accordance with the 
Principles of Laboratory Animal Care and with Dutch legislation. 
This study was carried out in accordance with the recommen-
dations of the Dutch Ethical Committee of Wageningen that 
approved the work. Blood was taken from mice being sacrificed, 
and serum was frozen in −80°C for later use. After mice (n = 4–6) 
were sacrificed, feces from colon was collected and snap-frozen. 
Distal ileum and proximal colon sections were isolated and fixed 
in Carnoy or snap-frozen in liquid nitrogen. BM, thymus, spleen, 
mesenteric lymph nodes (MLN), and Peyer’s patches (PPs) were 
isolated.
Bacterial cultures and supplementation
L. plantarum WCFS1, L. casei BL23, and B. breve DSM20213 were 
grown on MRS medium (Merck, Darmstadt, Germany) until sta-
tionary phase, frozen in glycerol, and stored in −80°C until use. 
Upon use, bacteria were thawed and 10× diluted in NaHCO3/
PBS buffer. Around 2 × 108 CFU in 200 μL were administered to 
mice by gavage, three times per week. Treatment of mice started 
at 6 weeks of age until 1 day before sacrifice at 16 weeks or until 
death.
histology and Fluorescence  
In Situ hybridization
Carnoy-fixed proximal colon sections were embedded in 
paraffin. Paraffin sections (5 μm) were attached to poly-l-lysine-
coated glass slides (Thermo Scientific, Germany). After overnight 
FigUre 1 | Treatment with L. plantarum prevented the age-related decline in colonic mucus barrier of accelerated aging Ercc1−/∆7 mice.  
(a) Representative pictures of proximal colon stained with PAS/Alcian Blue of 4-month-old (4 M) or 18-month-old (18 M) WT mice and 6-week-old (6 weeks) or 
16-week-old (16 weeks) Ercc1−/∆7 mice. (B) Quantitative measurement of mucus thickness in young and old WT and Ercc1−/∆ mice by ImageJ. (c) Representative 
pictures of proximal colon stained with H&E or PAS/Alcian Blue of Ercc1+/+ mice supplemented with control treatment, L. plantarum WCFS1 (LP), L. casei BL23 (LC), 
or B. breve DSM20213 (BB). (D) Representative pictures of proximal colon stained with H&E and PAS/Alcian Blue of Ercc1−/∆7 mice supplemented with control 
treatment, LP, LC, or BB. (e) Quantitative measurement of mucus thickness in Ercc1−/∆7 mice by ImageJ. (F) Fluorescence in situ hybridization (FISH) of proximal 
colon from Ercc1−/∆7 mice. Data represent the mean + SEM from four to six animals per group. ***p < 0.001. Scale bars histological pictures: 100 μm; scale bars 
FISH: 50 μm.
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incubation at 37°C, slides were de-waxed and rehydrated. Sections 
were stained with hematoxylin and eosin (H&E) and PAS/Alcian 
blue. Mucus layer thickness was measured using ImageJ software 
(NIH, MD, USA), as previously published (34). For detection of 
bacteria, tissue sections were used for fluorescence in situ hybridi-
zation (FISH), as previously published (8).
MiT-chips/16s sequencing
Microbiota composition in colonic content was analyzed by 
Mouse Intestinal Tract Chip (MITChip), as described previ-
ously (35). The data were normalized and analyzed using a set 
of R-based scripts in combination with a custom-designed 
relational database, which operates under the MySQL database 
management system. For the microbial profiling, the Robust 
Probabilistic Averaging signal intensities of 2667 specific probes 
for the 94 genus-level bacterial groups detected on the MITChip 
were used (36). Diversity calculations were performed using a 
microbiome R-script package (https://github.com/microbiome). 
Multivariate statistics, redundancy analysis (RDA), and principal 
response curves were performed in Canoco 5.0 and visualized in 
triplots or a principal response curves plot (37).
rna isolation and Transcriptome analysis
Total RNA was isolated from proximal colon (n = 3–6 per group) 
using the RNeasy kit (Qiagen) with a DNase digestion step 
according to the manufacturer’s protocol. Transcriptome analysis 
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on individual samples was performed as previously described 
(8). The gene expression datasets were deposited in NCBI’s Gene 
Expression Omnibus (GEO) and are accesible through GEO 
Series accession number: GSE87368.
general Flow cytometry Procedures
Single-cell suspensions of BM were obtained by crushing femurs, 
tibias, iliac crests, and sternum with mortar and pestle. BM cells 
were then filtered on a 40-μm cell strainer. A proportion of the 
BM cells was frozen for later use in in  vitro cultures. Spleen, 
MLN, PP, thymus, and peritoneal cavity single-cell suspensions 
were obtained by gently pushing cells through a 40-μm cell 
strainer with a syringe. All cells were stained for extracellular 
markers and dead cells were identified with fixable live/dead 
stain (Ebioscience, San Diego, CA, USA), after which intracel-
lular staining was enabled by fixing and permeabilizing cells 
with Fix/Perm buffer (Ebioscience) according to manufacturer’s 
instructions. Antibodies used for flow cytometric measurements 
are listed in Supplementary Table 1 in Data Sheet 1. All flow 
cytometric measurements were performed on a Canto II flow 
cytometer (BD Biosciences, Erembodegem, Belgium). FlowJo 
vX.07 software (Tree Star) was used for data analysis. Gating of all 
presented immune cell populations was based on single live cells.
spleen cell cultures
Splenic cells were cultured at 106 cells/mL for 4 days in the absence 
or presence of 5 μg/mL concanavalin A (ConA). Proliferation 
was measured by Ki-67 (Ebioscience). Supernatants were stored 
at −20°C. After thawing, levels of IL-2, IL-4, IL-6, IL-10, IL-17A, 
IFN-γ, and TNF were measured with the Cytometric Bead Array 
Th1/Th2/Th17 Kit (BD Biosciences), according to manufacturer’s 
instructions. Samples were acquired on a Canto II flow cytom-
eter. Data were analyzed using FCAP Array version 3.0 (BD 
Biosciences) software.
antibody Titers in serum
Levels of IgM, IgG1, IgG2a, IgG2b, IgG3, IgE, and IgA were 
analyzed in serum using ProcartaPlex Mouse Antibody Isotyping 
Panel kit on the Luminex platform (Affymetrix, Santa Clara, CA, 
USA) according to the manufacturer’s instructions. Data were 
acquired on a BioPlex 200 (Bio-Rad, Hercules, CA, USA) and 
analyzed with BioPlex software (version 5.0, Bio-Rad).
In Vivo immunization and  
antibody Detection
Primary and secondary T cell-dependent (TD) immune responses 
against TNP-KLH were measured 7 days after primary i.p. immu-
nization and 7 days after i.p. booster immunization. The primary 
immunization was performed at 8  weeks of age (TNP-KLH in 
alum), booster doses were injected at 12 weeks of age (TNP-KLH 
in PBS). Total and TNP-specific Ig subclasses were determined by 
sandwich ELISA as previously described (38).
statistical analysis
Values are expressed as mean + SEM. Normal distribution of the 
data was confirmed using the Kolmogorov–Smirnov test. Statistical 
comparisons were performed using the two-sided Student’s t-test. 
Where non-Gaussian distribution was demonstrated, we applied 
the non-parametric Mann–Whitney U test. Where no equal 
variances were observed, we applied the two-sided Student’s t-test 
with Welch’s correction. Statistical comparisons for lifespan data 
were performed using the log-rank (Mantel–Cox) test. Statistical 
comparisons for serum immunoglobulins were performed using 
two-way ANOVA, with subsequent Bonferroni posttests. Values 
of p < 0.05 were considered to be statistically significant. Values 
between p > 0.05 and p < 0.10 were considered as a trend.
resUlTs
The Mucus layer in the colon  
Declines with age
To assess the mucus barrier in normal and accelerated aging, 
we compared the proximal colon of 4-month-old (young) with 
18-month-old (aged) C57Bl/6 mice, and of 6-week-old (young) 
with 16-week-old (aged) Ercc1−/∆7 mice. We observed that in aged 
C57Bl/6 and Ercc1−/∆7 mice, a thinner mucus layer was present, 
compared with young C57Bl/6 and Ercc1−/∆7 mice (Figure 1A). 
With ImageJ, we measured the thickness of the mucus layer. 
In young C57Bl/6 and Ercc1−/∆7 mice, a mucus layer of ~20 μm 
was present, whereas in normal and accelerated aged mice, a 
significantly thinner mucus layer of less than 10 μm was observed 
(p < 0.001; Figure 1B).
Bacterial supplementations Do not 
change the Mucus layer in colon  
of Young WT Mice
To determine the effects of the three selected bacterial strains in 
the young intestine, we analyzed proximal colon tissues of WT 
mice that were treated with L. plantarum WCFS1, L. casei BL23, 
or B. breve DSM20213 for 10 weeks. No change in tissue integrity 
(H&E) or mucus layer (PAS/Alcian Blue) was observed in the 
colon after supplementation with bacterial strains (Figure 1C).
age-related Decline in the Mucus Barrier 
is Prevented by supplementation of 
Ercc1−/∆7 Mice with L. plantarum
Because the mucus layer declines with age, we questioned whether 
bacterial supplementation of Ercc1−/∆7 mice prevents the decline 
in mucus barrier. Colon tissue of 10-week treated Ercc1−/∆7 mice 
was checked for tissue integrity and mucus layer thickness. In 
contrast to our findings in WT mice, bacterial supplementation 
had significant effects on tissue integrity and the mucus layer. 
In Ercc1−/∆7 mice supplemented with L. plantarum, the colon 
showed a thicker mucus layer than their controls (Figure 1D). 
L. plantarum supplementation completely prevented age-related 
decline in the mucus layer compared with controls (p < 0.001; 
Figure 1E), resulting in a mucus thickness comparable to young 
WT mice. Spatial compartmentalization of bacteria in the colon 
was improved after L. plantarum supplementation (Figure 1F), 
as demonstrated by FISH analyses. On the contrary, Ercc1−/∆7 
mice supplemented with L. casei or B. breve showed loss of tis-
sue integrity (Figure 1D). No difference in mucus thickness was 
FigUre 2 | The effect of bacterial supplementations on colonic microbiota composition in Ercc1−/∆7 mice. Redundancy analysis of the microbial 
composition after bacterial supplementations, on genus-like level of the MITChip analysis. Mice belonging to control-, LP-, LC-, and BB-treated groups are indicated 
by white squares, yellow diamonds, green circles, and blue rectangles, respectively. First and second ordination axes are plotted, showing 4.9 and 3.6% of the 
variability in the dataset, respectively. No significant changes were observed. LP, L. plantarum WCFS1; LC, L. casei BL23; BB, B. breve DSM20213.
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observed after supplementation with L. casei (Figure 1E). B. breve 
supplementation resulted in a deteriorated mucus layer and a loss 
in mucus thickness (p < 0.001; Figure 1E). B. breve supplementa-
tion also resulted in less spatial compartmentalization of bacteria 
in the colon of Ercc1−/∆7 mice (Figure 1F).
Collectively, these data show that L. plantarum supplementa-
tion improves the mucus layer in the aged (but not young) colon. 
In addition, supplementation with L. casei or B. breve exacerbates 
the age-related decline of mucus barrier in the colon.
Bacterial supplementation associated 
with Minor alterations in colonic 
Microbiota composition
As we introduced bacteria by bacterial supplementations into the 
intestinal microbial community, we investigate whether changes 
in the microbiota composition were underlying the observed 
changes in the mucus barrier of Ercc1−/∆7 mice. Microbiota com-
position was determined by performing 16S rRNA gene micro-
biota profiles of colonic content. The bacterial supplementations 
did not significantly alter microbial diversity nor richness (data 
not shown).
Redundancy analysis showed that 10.1% of the total 
variability of the gut microbiota can be related to the bacterial 
supplementations (Figure  2). No statistical significance was 
established. The first ordination axis explained 4.9% of the vari-
ability and separated Ercc1−/∆7 mice supplemented with either of 
the three bacterial strains from the control Ercc1−/∆7 mice. The 
second ordination axis explained 3.6% of the variability but did 
not result in a separation between groups. The third ordination 
axis explained an additional 1.6% of the variability (data not 
shown).
FigUre 3 | Bacterial supplementation induced changes in bacterial taxa in the colon of Ercc1−/∆7 mice. Wilcoxon tests comparing mice treated with 
bacterial strains with control group. Data represent n = 4–6 mice per group. *p < 0.05.
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To assess whether significant changes in the microbial 
genus-like bacterial groups existed after different bacterial sup-
plementations in Ercc1−/∆7 mice, we performed the Wilcoxon 
test. Subdoligranulum was higher in mice supplemented with 
L. casei (p < 0.05), whereas it tended to be higher in mice supple-
mented with B. breve (p = 0.05), as compared with control mice 
(Figure  3). Akkermansia muciniphila tended to be less present 
(p =  0.06) in mice supplemented with L. plantarum compared 
with control mice. Eubacterium plexicaudatum and a close 
relative to Anaerostipes caccae tended to be higher (p = 0.06) in 
Ercc1−/∆7 mice supplemented with L. casei.
These data demonstrate some differences in microbial species 
between control-treated Ercc1−/∆7 mice and Ercc1−/∆7 mice treated 
with bacterial supplementations.
Distinct gene expression Profiles in colon 
after each Bacterial supplementation
To understand the mechanisms by which bacterial supplementa-
tion changes the mucus barrier, we performed transcriptome 
analysis on the proximal colon of Ercc1−/∆7 mice. Gene expression 
microarrays on total proximal colon samples from Ercc1−/∆7 mice 
treated with bacterial supplementations or control treatment 
revealed relatively low numbers of differentially expressed genes: 
84 by L. plantarum, 238 by L. casei, and 384 by B. breve. Only 
a few genes were overlapping between two or three different 
bacterial supplementations, whereas most of the differentially 
expressed genes were distinctly regulated by one of the treatments 
(Figure 4).
Several growth- and immune-related genes were differentially 
expressed after bacterial supplementation. Apolipoprotein 
(APO) A-1, APOA-4, suppressor of cytokine signaling (SOCS) 
3, and toll-like receptor (TLR) 4 were upregulated more than 
1.2-fold after L. plantarum supplementation (Data Sheet 2 in the 
Supplementary Material). Several immunoglobulin variable genes 
and TLR13 were upregulated after administration of L.  casei, 
whereas defensin 40β was 1.3-fold downregulated. Defensin 24α, 
amphiregulin, and keratinocyte growth factor 7 (FGF7) were 
upregulated more than 1.4-fold after administration of B. breve, 
while TLR6, TLR7, and CCL3 (MIP-1α) were more than 1.2-fold 
downregulated (Data Sheet 2 in the Supplementary Material). 
Remarkably, we found no significant up- or downregulation in 
any mucin.
Bacterial supplementation alters growth- 
and immune-related Pathways in colon
Because we found relatively low numbers of differentially 
expressed genes, we applied a gene set enrichment analysis 
(GSEA) (39) to gain insight into the regulated pathways by 
bacterial supplementations. Upstream regulators that can explain 
the observed changes in gene expression were identified using 
Ingenuity Upstream Regulator Analysis.
Gene set enrichment analysis revealed that L. plantarum sup-
plementation significantly enhanced several processes involved 
in growth and cell cycle, and immunity (Supplementary Table 2 
in Data Sheet 1), such as “Type II Interferon Signaling,” “VIP 
pathway,” and “IL8/CXCR1 pathway.” Interestingly, in the top-10 
FigUre 4 | Venn diagrams of differentially regulated genes in colon of 
Ercc1−/∆7 mice after bacterial supplementations. Total number of genes 
altered in the proximal colon of Ercc1−/∆7 mice treated with L. plantarum 
WCFS1 (LP), L. casei BL23 (LC), or B. breve DSM20213 (BB) compared with 
control-treated Ercc1−/∆7 mice. Venn diagram of the total number of genes 
upregulated and downregulated in the proximal colon of Ercc1−/∆7 mice 
treated with LP, BB, or LC (p < 0.05 and >1.2-fold difference).
TaBle 1 | activation z-scores of upstream regulators in proximal colon 
of Ercc1−/Δ7 mice after bacterial supplementations L. plantarum WcFs1 
(lP), L. casei Bl23 (lc), or B. breve DsM20213 (BB) as determined by 
ingenuity.
Upstream regulator lP lc BB
Leptin 2.41
EGF 2.36 3.36
IL4 2.18
IFN-γ 2.00 −1.35
PDGF BB 2.00 1.15
P38 MAPK 1.97
CD40L 1.96
Palmitic acid 1.96
EGR1 1.95
IGF1 1.82
IL1β 1.77
Ethanol 1.76
CREB1 1.55
CREBBP 1.54
TNF 1.53
KLF4 2.04
Resistin-like β 2.00
PML −1.73
miR-4800-5p −1.98
GATA3 −1.98
MTOR −2.00
miR-4455 −2.22
ADCYAP1 2.60
EDN1 2.17
WNT3A 2.16
VIP 1.95
FGF2 1.74
GLI1 1.63
miR-6967-5p −1.58
Klra7 (includes others) −1.87
IgG −1.89
EZH2 −1.96
GATA2 −2.00
ANXA7 −2.00
miR-4707-5p −2.16
ITK −2.19
miR-4459 −2.63
Upstream regulators involved in growth and cell cycle are highlighted in blue; upstream 
regulators involved in immunity are highlighted in orange. Cut-off values for activation 
z-score ≥1.5 or ≤−1.5 combined with p < 0.05. Activated in blue, inhibited in red.
ADCYAP, adenylate cyclase activating polypeptide; ANX, annexin; CREB(BP), cAMP-
responsive element (binding protein); EDN, endothelin; EGF, epidermal growth factor; 
EGR, early growth response protein; EHZ, enhancer of zeste homolog; FGF, fibroblast 
growth factor; GLI, glioma-associated oncogene family zinc finger; IFN, interferon; IGF, 
insulin-like growth factor; ITK, IL-2-inducible T cell kinase; KLF, Kruppel-like factor; 
Klra, killer cell lectin-like receptor, subfamily A; LEP, leptin; MTOR, mechanistic target of 
rapamycin; PDGF, platelet-derived growth factor; PML, promyelocytic leukemia protein; 
RETNLB, resistin-like β; TNF, tumor necrosis factor; VIP, vasoactive intestinal peptide; 
WNT, wingless-type MMTV integration site family.
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of upregulated pathways, three pathways were linked to DNA 
repair: the “Fanconi Pathway,” “ATRBRCA pathway,” and the 
“Fanconi anemia pathway.” Several growth factors were activated 
after L. plantarum supplementation: leptin, epidermal growth 
factor (EGF), platelet-derived growth factor (PDGF) BB, early 
growth response protein (EGR) 1, and insulin-like growth fac-
tor (IGF) 1 (Table  1). Inflammatory cytokines (IFN-γ, IL-1β, 
IL-4, TNF) and CD40L (CD154) were activated in colon of mice 
supplemented with L. plantarum, compared with colon of mice 
supplemented with control treatment.
Lactobacillus casei supplementation enhanced several pro-
cesses involved in growth and cell cycle, like “Mitotic G1-G1 
S Phases,” “DNA replication,” “Synthesis of DNA,” and “G1 S 
transition” (Supplementary Table 2 in Data Sheet 1). In addition, 
the “NOD-like receptor signaling pathway” was enhanced after 
L. casei supplementation, as well as and the “Unfolded protein 
response” (UPR), indicated endoplasmatic reticulum (ER) stress. 
Upstream regulators resistin-like β (RTNLB; activated) and 
GATA3 (inhibited) were regulated in the colon of mice supple-
mented with L. casei (Table 1).
Several metabolic pathways were enhanced in colon of 
B.  breve-supplemented mice (Supplementary Table 2 in Data 
Sheet 1). Of note, “Protein folding” was upregulated. In contrast 
to L.   plantarum and L. casei supplementation, B. breve supple-
mentation significantly inhibited several processes involved in 
immunity, such as “IL2 STAT5 pathway,” “Immunoregulatory 
interactions between lymphoid/non-lymphoid cells,” “Type 
II Interferon signaling,” “IL4 2 pathway,” and “IL6 7 pathway” 
(Supplementary Table 3 in Data Sheet 1). B. breve supplementa-
tion activated EGF and inhibited fibroblast growth factor (FGF) 2. 
IgG, GATA2, and IL-2-inducible T cell kinase (ITK) were inhib-
ited in colon of mice supplemented with B. breve. In line with 
GSEA, IFN-γ was inhibited as well after B. breve supplementation.
These data indicate that immune pathways in the colon are 
enhanced by L. plantarum and L. casei, but are inhibited by 
B. breve supplementation.
FigUre 5 | Distribution of B cells and T cells in Peyer’s patches (PP) 
and mesenteric lymph nodes (Mln) upon bacterial supplementation 
in Ercc1−/∆7 mice. (a,B) Mean frequencies of B and T cells in PP and MLN 
were determined by flow cytometry. B cells were defined as CD19+, T cells 
were defined as CD3+. (c) Flow cytometric analysis of CD3+CD4+CD8− 
regulatory T (Treg) cells in MLN. (D) Mean frequencies of Treg cells in MLN. 
Data represent the mean + SEM from four to six animals per group. LP, 
L. plantarum WCFS1; LC, L. casei BL23; BB, B. breve DSM20213. 
*p < 0.05; **p < 0.01.
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L. plantarum and L. casei supplementation 
induce regulatory T cells in Mln
Based on the regulation of immune genes by bacterial supple-
mentations, we tested whether the distribution of immune cells 
was altered in mucosal immune organs of Ercc1−/∆7 mice.
First, we evaluated changes in distribution of immune cells 
in PPs and MLN. B cell frequencies were reduced in PP and 
MLN (p <  0.05) after L. casei supplementation in Ercc1−/∆7 
mice (Figure  5A). By contrast, frequencies of T cells were 
increased in PP (p <  0.01) and MLN (p <  0.05; Figure  5B). 
The frequencies of regulatory T (Treg) cells in MLN were 
increased after L. plantarum and L. casei supplementation 
(p < 0.05; Figures 5C,D). No changes in distribution of B and 
T cells were observed upon bacterial supplementation in WT 
mice, except for a tendency to decreased Treg cells after L. casei 
supplementation (p =  0.09; Supplementary Figure 1 in Data 
Sheet 1).
L. casei elevates systemic inflammatory 
Markers
Next, we assessed distribution of immune cells in the spleen. 
We noted that the relative spleen weight increased after L. casei 
supplementation in Ercc1−/∆7 mice (Supplementary Figure 2A in 
Data Sheet 1). Absolute numbers of spleen cells were not affected 
by bacterial supplementations (data not shown). Splenic B cell 
frequencies tended to be decreased after L. casei supplementa-
tion (p = 0.06; Figure 6A), but no changes in T cell frequencies 
were observed (Figure 6B). Treg cell frequencies in the spleen 
were increased after L. casei supplementation in Ercc1−/∆7 mice 
(p < 0.05; Figure 6C).
Increased frequencies of CD11b+Ly6G−CD68+Ly6Chi mono-
cytes (p  <  0.01; Figures  6D,E) and a tendency to increased 
frequencies of CD11b+CD68intLy6CintLy6G+ neutrophils were 
observed after L. casei supplementation (p =  0.07; Figure  6F). 
In addition, the proportions of CD3+CD4+RORγt+ Th17 cells 
(Supplementary Figure 2B in Data Sheet 1) were increased after 
L. casei supplementation (p < 0.05; Figure 6G). A 4-day culture 
of splenocytes stimulated with concanavalin A (ConA), also 
showed increased IL-17A production (p  <  0.01; Figure  6H) 
and a decreased T cell proliferation in splenocytes derived from 
L. casei-treated mice (p < 0.01; Figure 6I). None of these changes 
were observed in Ercc1−/∆7 mice treated with L. plantarum or 
B. breve, and in WT mice treated with each of the bacterial sup-
plementations (Supplementary Figure 3 in Data Sheet 1). These 
data suggest that L. casei, in contrast to L. plantarum and B. breve, 
raises several inflammatory markers in Ercc1−/∆7 mice.
lymphocyte and Myeloid Development 
affected after L. plantarum or L. casei 
supplementation
We subsequently investigated the development of B cells and 
myeloid cells in BM and of T cells in thymus of Ercc1−/∆7 mice, 
as the observed changes in cell distribution in PP, MLN, and 
spleen might be explained by an altered migration or produc-
tion. Absolute numbers in the BM were unchanged after bacte-
rial supplementation (data not shown). In the BM, we observed 
significantly higher Lin−CD117hiCD11c−CD135−CD16/32+ 
granulocyte–monocyte precursor (GMP), CD11b+Ly6G+ 
neutrophil, and Ly6ChiCD31− monocyte frequencies after 
L.  casei supplementation (Figures  7A–C). Frequencies of total 
CD19+CD45R+ B-lineage cells were decreased after L. plantarum 
(p < 0.05) and L. casei supplementation (p < 0.001), but not after 
B. breve supplementation (Figure 7D). We observed a reduction 
in all B-lineage subsets, except pro-B cells, after L. casei and 
L. plantarum supplementation (data not shown). In thymus, only 
L. casei supplementation caused changes in cell distribution, with 
significantly reduced CD3−CD4+CD8+ double-positive (DP) cell 
numbers (Figures 7E–H).
In WT mice, we found no effect of bacterial supplementations 
on distribution of immune cells in BM or thymus, except for 
B-lineage cells after L. plantarum and L. casei supplementation 
(Supplementary Figure 4 in Data Sheet 1).
FigUre 6 |  L. casei supplementation of Ercc1−/∆7 mice raised inflammatory markers in spleen. (a,B) Mean frequencies of B and T cells in spleen were 
determined by flow cytometry. B cells were defined as CD19+, T cells were defined as CD3+. (c) Mean frequencies of Treg cells in spleen. (D) Flow cytometric 
analysis of splenic monocytes. CD11b+Ly6G−CD68+ cells were divided in Ly6Chi, Ly6Cint, and Ly6Clo monocytes. (e–g) Mean frequencies of Ly6Chi monocytes, 
neutrophils, and CD3+CD4+CD8−Rorγt+ Th17 cells were determined by flow cytometry. (h) Mean concentration of IL-17A production by splenocytes stimulated with 
ConA for 4 days, as determined by Cytometric Bead Array. (i) Mean proliferating T cells (Ki-67+) in splenocyte culture stimulated with ConA for 4 days, as 
determined by flow cytometry. Data represent the mean + SEM from four to six animals per group. *p < 0.05; **p < 0.01. LP, L. plantarum WCFS1; LC, L. casei 
BL23; BB, B. breve DSM20213.
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Bacterial supplementations Do not alter 
lifespan of Ercc1−/∆7 Mice
The accelerated aging of Ercc1−/∆7 mice enabled us to assess the 
potential life-extending properties of the bacterial strains. No 
significant change in lifespan of Ercc1−/∆7 mice was observed 
after lifelong supplementation with L. plantarum or L. casei 
(Supplementary Figure 5 in Data Sheet 1).
L. casei supplementation  
increases igg serum Titers
Because L. casei supplementation led to decreased B cell pro-
portions in several immune organs of Ercc1−/∆7 mice, we tested 
whether serum antibody titers in Ercc1−/∆7 mice were altered. Total 
IgG1 and IgG2b (but not IgG2a, IgG3, IgE, and IgA) titers were 
significantly increased after L. casei supplementation (Figure 8). 
L. plantarum and B. breve supplementation did not significantly 
change titers of any Ig subclass.
immune competence improved by L. casei 
and L. plantarum supplementation
To test whether changes in immune cell distribution also impact 
immune competence, we analyzed the B cell response of Ercc1−/∆7 
mice to the T cell-dependent antigen TNP-KLH. Specific anti-
TNP-KLH Ig titers of the three tested isotype classes (IgM, IgG1, 
FigUre 8 |  L. casei supplementation increased igg1 and igg2b titers 
in Ercc1−/∆7 mice. Mean titers of IgG1, IgG2a, IgG2b, IgG3, IgE, and IgA in 
serum, as determined by Luminex. Data represent the mean + SEM from 
three to six animals per group. **p < 0.01; ***p < 0.001. LP = L. plantarum 
WCFS1; LC = L. casei BL23; BB = B. breve DSM20213.
FigUre 7 |  L. casei or L. plantarum supplementation altered myeloid and lymphoid development in bone marrow and thymus of Ercc1−/∆7 mice. 
(a–D) Mean frequencies in bone marrow (BM) were determined by flow cytometry. Granulocyte–monocyte precursors (GMP) were defined as 
Lin−CD117hiCD11c−CD135−CD16/32+, neutrophils as CD11b+Ly6G+, monocytes as Ly6ChiCD31−, and B-lineage cells as CD19+CD45R+. (e–h) Mean absolute 
numbers were determined by cell counts and flow cytometry. Double-negative (DN) cells were defined as CD3−CD4−CD8−, double-positive (DP) cells as 
CD3−CD4+CD8+, CD4+ single-positive (SP) as CD3+CD4+CD8−, and CD8+ SP as CD3+CD4−CD8+. Data represent the mean + SEM from four to six animals per 
group. *p < 0.05; **p < 0.01; ***p < 0.001. LP, L. plantarum WCFS1; LC, L. casei BL23; BB, B. breve DSM20213.
FigUre 9 | supplementation of L. plantarum and L. casei increased 
specific anti-TnP-Klh antibody responses of Ercc1−/∆7 mice. Mean 
TNP-specific IgM, IgG1, and IgG2a concentrations in serum were determined 
by ELISA, 7 days after primary immunization (prime, age 9 weeks), or 7 days 
after booster immunization (boost, age 13 weeks). Data represent the 
mean + SEM of 6–12 animals per group. ***p < 0.001. LP, L. plantarum 
WCFS1; LC, L. casei BL23.
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IgG2a) after primary and booster immunization were consist-
ently higher after L. plantarum and L. casei supplementation 
(Figure 9). In particular, IgG1 titers after booster immunization 
increased in both L. plantarum- and L. casei-supplemented mice 
compared with control-treated mice (p < 0.001).
From these findings, we conclude that L. plantarum and L. casei 
enhance T cell-dependent B cell responses in Ercc1−/∆7 mice.
DiscUssiOn
The effects of bacterial supplementations on the intestinal barrier 
and cellular parameters of immunity were studied in fast aging 
11
van Beek et al. Lactobacillus Prevents Age-Related Mucus Decline
Frontiers in Immunology | www.frontiersin.org October 2016 | Volume 7 | Article 408
Ercc1−/∆7 mice. We observed that the mucus layer in the colon 
declines with age and that bacterial supplementation may prevent 
or exacerbate the age-related decline in the mucus layer, depend-
ent on the specific bacterial strain. Additionally, we demonstrated 
a marked difference in the response to bacterial supplementations 
between Ercc1−/∆7 mice and WT mice. Finally, supplementa-
tion with L. casei BL23 profoundly changed the distribution of 
immune cells and supplementation with L. plantarum WCFS1 or 
L. casei BL23 improved immune competence in Ercc1−/∆7 mice.
Recently, we showed the age-related decline in mucus bar-
rier of C57Bl/6 mice as well (Sovran et  al., unpublished data). 
Importantly, we report that the mucus barrier declines with age, 
in aged C57Bl/6 and Ercc1−/∆7 mice (Figure 1). This finding adds 
another age-related phenotype to the wide spectrum of age-
related phenotypes observed in Ercc1−/∆7 mice (40). Moreover, 
we report that the age-related decline in mucus barrier can be 
modulated by bacterial supplementation. L. plantarum prevented 
the decline in mucus barrier. L. plantarum is able to bind to 
mucus with a mannose-specific adhesin, which is described as 
a potential probiotic feature (41). In total, L. plantarum harbors 
four mucus-binding proteins (42). Based on the improved spatial 
compartmentalization of bacteria after L. plantarum supplemen-
tation, we postulate that L. plantarum adheres to the mucus. In 
addition, we found that L. plantarum supplementation tended to 
decrease the abundance of Akkermansia muciniphila (Figure 3), 
which is known as a mucus degrader (43). Thus, it would be con-
ceivable that mucus degradation is decreased after L. plantarum 
supplementation. By contrast, B. breve is known as a mucus 
degrader (44), and could, therefore, be directly responsible for the 
decrease in mucus thickness in the colon of B. breve-treated mice. 
Interestingly, several pathways involved in protein folding and the 
UPR were upregulated after L. casei and B. breve supplementation 
(Data Sheet 2 in the Supplementary Material). A high demand 
for synthesis of secretory proteins (such as mucins) induces ER 
stress, which in turn induces the UPR (45). The close proximity 
of bacteria to the epithelium in L. casei- and B. breve-treated mice 
might induce a high demand for mucin production and secre-
tion, leading to induction of ER stress and UPR. There is indeed 
evidence that defects in MUC2 mucin and a subsequent defective 
mucus layer lead to ER stress and UPR (46).
Microbiota profiling showed that only few microbial species 
are slightly altered by bacterial supplementation (Figures 2 and 
3). Therefore, most of the observed effects in the mucus barrier 
and immune system may be directly linked to the supplementa-
tion of each of the bacterial strains.
We found that the different bacterial strains elicited char-
acteristically different responses in gene regulation in the 
colon (Figure  4). L. plantarum is known for its moderately 
pro-inflammatory profile, and relatively high IL-10 induction, 
when tested in human PBMC cultures (28, 47). In line with these 
studies, several upstream regulators predicted to be activated 
after L. plantarum supplementation included the inflammatory 
cytokines IFN-γ, IL-1β, IL-4, and TNF. The association between 
increased activation of inflammatory cytokines and the improved 
integrity of the colon after L. plantarum supplementation raises 
the possibility that it might be beneficial to locally increase 
inflammatory cytokine levels. This suggestion is corroborated by 
the absence of activation of these inflammatory cytokines after 
L. casei or B. breve supplementation, which did not improve or 
exacerbate the age-related decline in mucus integrity. A “tonic” 
level of constitutive TLR activation by commensal bacteria was 
previously shown to be crucial in the recovery from DSS-induced 
epithelial damage due to the role of NF-κB in epithelial repair 
processes (48). This notion that “physiological pro-inflammatory 
signals” is required for intestinal homeostasis is also supported 
by studies using epithelium-specific iκB kinase-γ (or NEMO) 
ablation in mice. These mice develop spontaneous colitis due to 
the failure of NF-κB to induce epithelial repair and steady-state 
production of innate effector mechanisms in the intestine (49). 
TLR2 signaling has been implicated in tight junction regulation 
in vivo and in vitro (13). Thus, it is possible that aged mice have 
sub-optimal level of TLR stimulation in the intestine to promote 
innate barrier defenses and that this is enhanced by L. plantarum, 
but not by L. casei and B. breve.
Remarkably, none of the significantly regulated genes were 
directly linked to mucus production. However, while performing 
Upstream Regulator Analysis, growth factors, such as EGF, IGF1, 
and EGR1, were predicted to be activated after L. plantarum sup-
plementation. Together, these findings may indicate that mucus 
production by goblet cells is not directly enhanced, but is part 
of general epithelial integrity, supported by a number of growth 
factors.
Because many regulated genes involved immune-related 
genes, we additionally analyzed the makeup of the immune 
system after bacterial supplementation. Whereas supplementa-
tion with B. breve exacerbated the age-related decline in mucus 
barrier in colon, it did not cause any changes in mucosal or 
systemic immunity (Figures  5–8). Oppositely, L. casei supple-
mentation caused various signs of inflammation, such as Ly6Chi 
monocyte and neutrophil influx and production in spleen and 
BM, respectively. These inflammatory signs were coincided with 
the general decrease in B cell frequencies (also in the BM) and 
double-positive thymocytes. There is evidence that neutrophils 
in the BM are primed by microbial ligands (50). The effects of 
microbiota-derived signals on priming B and T cells in the BM 
have not been previously described. Our study suggests an, up to 
now, unknown link between microbiota, intestinal barrier, and B 
and T cell precursors. Specific precursor stages (i.e., small resting 
pre-B cells) were significantly decreased after L. casei supplemen-
tation, and to a lesser extent after L. plantarum supplementation. 
In the case of L. plantarum supplementation, we suggest that 
improved intestinal barrier function might alter circulating 
microbiota-derived products, such as peptidoglycan (PGN) and 
lipopolysaccharide (LPS). For instance, hematopoietic stem cells 
are damaged after chronic exposure to LPS (51). Interestingly, the 
decrease in small resting pre-B cells after L. casei supplementation 
(and to lesser extent by L. plantarum) was the only finding that 
could be reproduced in WT mice supplemented with these bacte-
rial strains (Supplementary Figure 4 in Data Sheet 1). This may 
indicate that the effect of L. casei and L. plantarum supplementa-
tion on B cell development is independent of age.
A previous study showed lifespan extension after B. animalis 
supplementation (21). Therefore, we performed a lifespan study 
for L. plantarum and L. casei, which indicated that neither of them 
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is shortening or extending lifespan (Supplementary Figure 5 in 
Data Sheet 1).
Surprisingly, anti-TNP-KLH IgG1 titers in serum increased 
not only after L. plantarum but also after L. casei supplementa-
tion (Figure  9). This increase suggests that a demise in B cell 
development and B cell distribution does not necessarily translate 
into impaired B cell function. Previously, it has been shown that 
antigen-specific antibody titers can be enhanced by probiotic 
supplementation in aged mice (20), but data on B cell develop-
ment are lacking.
The effects of the candidate probiotic strains were pro-
nounced on the mucus barrier in the colon of Ercc1−/∆7 mice 
compared with WT mice. It has been shown in previous studies 
that strains, such as L. casei and B. breve, have beneficial effects 
on immunological parameters and intestinal barrier function in 
young mice (29–31). In our hands, L. casei and B. breve had 
no effect on mucus barrier or systemic immunity in young WT 
mice (except for the above-discussed finding on B cell develop-
ment). A severe deteriorating effect, however, was observed on 
the mucus barrier or systemic immunity in Ercc1−/∆7 mice. These 
findings highlight the need for caution in translating beneficial 
effects of probiotics observed in young animals or humans to 
the elderly.
Our study has a number of limitations. We observed remark-
able changes in the mucus layer, but could not pinpoint a single 
gene that is directly linked to the mucus layer. Furthermore, we 
did not include commercially available probiotic bacterial strains, 
such as Lactobacillus rhamnosus GG, or a non-probiotic bacterial 
strain. Nevertheless, our study reveals a previously unknown 
effect of age on the mucus barrier. We also show that it is pos-
sible to modulate this age-related decline in the mucus barrier 
by supplementation of bacterial strains, with coinciding effects 
on systemic immunity. More research is warranted to elucidate 
the interplay between bacteria, the aged gut epithelium, and the 
immune system.
Our data provide evidence that a comprehensive analysis of 
the intestinal barrier and immunity are needed in order to evalu-
ate how bacterial supplementation contributes to the restoration 
of the age-related decline in intestinal barrier. A positive finding 
was that probiotic strains, such as L. plantarum, might contribute 
to maintenance of intestinal integrity by preventing age-related 
deterioration of the colonic mucus layer.
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sUPPleMenTarY TaBle 1 | Used antibodies in flow cytometry.
sUPPleMenTarY TaBle 2 | Top-10 biological processes upregulated 
(as determined with gsea) by bacterial supplementations in proximal 
colon of Ercc1−/∆7 mice treated with L. plantarum WcFs1 (lP), L. casei 
Bl23 (lc), or B. breve DsM20213 (BB).
sUPPleMenTarY TaBle 3 | Top-10 biological processes downregulated 
(as determined with gsea) by bacterial supplementations in proximal 
colon of Ercc1−/∆7 mice treated with L. plantarum WcFs1 (lP), L. casei 
Bl23 (lc), or B. breve DsM20213 (BB).
sUPPleMenTarY FigUre 1 | Distribution of B cells and T cells in 
Peyer’s patches and mesenteric lymph nodes not changed upon 
bacterial supplementation in Ercc1+/+ mice. (a/B) Mean frequencies were 
determined by flow cytometry. B cells were defined as CD19+, T cells were 
defined as CD3+. (c) Mean frequencies of CD3+CD4+CD8−FoxP3+ regulatory T 
(Treg) cells in MLN. Data represent the mean + SEM from four to six animals per 
group. LP, L. plantarum WCFS1; LC, L. casei BL23; BB, B. breve DSM20213.
sUPPleMenTarY FigUre 2 | increased relative spleen weight after 
L. casei supplementation of Ercc1−/∆7 mice. (a) Spleen weights relative to 
body weight. Data represent mean spleen weights + SEM of four to six animals 
per group. (B) Flow cytometric analysis of splenic Th17 cells. CD3+CD4+CD8− 
cells were gated for RORγt and FSC (forward scatter).
sUPPleMenTarY FigUre 3 | Bacterial supplementation of Ercc1+/+ mice 
did not change splenic parameters. (a) Mean frequencies of Treg cells in 
spleen. (B–D) Mean frequencies of Ly6Chi monocytes, neutrophils, and 
CD3+CD4+CD8−Rorγt+ Th17 cells were determined by flow cytometry. (e) Mean 
concentration of IL-17A production by splenocytes stimulated with ConA for 
4 days, as determined by Cytometric Bead Array. (F) Mean proliferating T cells 
(Ki-67+) in splenocyte culture stimulated with ConA for 4 days, as determined by 
flow cytometry. Data represent the mean + SEM from four to six animals per 
group. LP, L. plantarum WCFS1; LC, L. casei BL23; BB, B. breve DSM20213.
sUPPleMenTarY FigUre 4 | L. casei supplementation altered B cell 
development in bone marrow of Ercc1+/+ mice. (a–e) Mean frequencies in 
bone marrow (BM) were determined by flow cytometry. Granulocyte–monocyte 
precursors (GMP) were defined as Lin−CD117hiCD11c−CD135−CD16/32+, 
neutrophils as CD11b+Ly6G+, monocytes as Ly6ChiCD31−, B-lineage cells as 
CD19+CD45R+, and small resting pre-B cells as sIgκ/λ−cIgM+CD2+. (F) Mean 
absolute numbers were determined by cell counts and flow cytometry. 
Double-positive (DP) cells were defined as CD3−CD4+CD8+. Data represent the 
mean + SEM from four to six animals per group. *p<0.05. LP, L. plantarum 
WCFS1; LC, L. casei BL23; BB, B. breve DSM20213.
sUPPleMenTarY FigUre 5 | Bacterial supplementations did not 
change lifespan of Ercc1−/∆7 mice. Data represent 11–12 animals per group 
(with an additional 6 animals per group censored at 16 weeks). LP, L. plantarum 
WCFS1; LC, L. casei BL23.
DaTa sheeT 2 | Total file with differentially expressed genes after 
bacterial supplementations.
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